Literature DB >> 23585504

Ciprofloxacin-associated posterior reversible encephalopathy.

Waleed Hammad Al Bu Ali1.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiological syndrome characterised by numerous symptoms and of no specific aetiology. Headache, confusion, seizures, cortical visual disturbances or blindness are the key symptoms. As this syndrome is reversible and readily treated by interrupting or discontinuing the aetiology, it should sharply be acknowledged. Ciprofloxacin was associated with PRES in an adolescent male treated from chest infection. It was managed in a hospital intensive care unit and was observed until disappearance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23585504      PMCID: PMC3645815          DOI: 10.1136/bcr-2013-008636

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 2.  Posterior reversible encephalopathy syndrome in systemic lupus erythematosus.

Authors:  Khalil El Karoui; Moglie Le Quintrec; Eric Dekeyser; Aude Servais; Aurélie Hummel; Fouad Fadel; Fadi Fakhouri
Journal:  Nephrol Dial Transplant       Date:  2007-12-01       Impact factor: 5.992

3.  Pediatric posterior reversible leukoencephalopathy syndrome and NSAID-induced acute tubular interstitial nephritis.

Authors:  Shoji Yokobori; Hiroyuki Yokota; Yasuhiro Yamamoto
Journal:  Pediatr Neurol       Date:  2006-03       Impact factor: 3.372

Review 4.  Cortical blindness: clinical and radiologic findings in reversible posterior leukoencephalopathy syndrome: case report and review of the literature.

Authors:  Alon Kahana; Howard A Rowley; Joel M Weinstein
Journal:  Ophthalmology       Date:  2005-02       Impact factor: 12.079

Review 5.  Magnetic resonance imaging in Posterior Reversible Encephalopathy Syndrome: report of three cases and review of literature.

Authors:  Vanina Finocchi; Alessandro Bozzao; Michela Bonamini; Michele Ferrante; Andrea Romano; Claudio Colonnese; Luigi Maria Fantozzi
Journal:  Arch Gynecol Obstet       Date:  2004-10-09       Impact factor: 2.344

Review 6.  Cyclosporine neurotoxicity.

Authors:  M Hauben
Journal:  Pharmacotherapy       Date:  1996 Jul-Aug       Impact factor: 4.705

7.  Hypertensive brainstem encephalopathy without parieto-occipital lesion--two case reports.

Authors:  Yoshimitsu Doi; Fumiharu Kimura; Tohru Fujiyama; Chieko Fujimura; Takuya Nishina; Toshihiko Sato; Takafumi Hosokawa; Hideaki Uehara; Simon Ishida; Toshiaki Hanafusa
Journal:  Neurol Med Chir (Tokyo)       Date:  2006-02       Impact factor: 1.742

8.  Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings.

Authors:  Alexander M McKinney; James Short; Charles L Truwit; Zeke J McKinney; Osman S Kozak; Karen S SantaCruz; Mehmet Teksam
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

9.  Posterior leukoencephalopathy syndrome in children and adolescents.

Authors:  Füsun Alehan; Ilknur Erol; A Muhtesem Agildere; Figen Ozcay; Esra Baskin; Nurcan Cengiz; Bülent Alioglu; Mehmet Haberal
Journal:  J Child Neurol       Date:  2007-04       Impact factor: 1.987

10.  Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions.

Authors:  Richard B Schwartz
Journal:  Neurologist       Date:  2002-01       Impact factor: 1.398

View more
  3 in total

Review 1.  Neuropsychiatric Effects of Antimicrobial Agents.

Authors:  Nicholas Zareifopoulos; George Panayiotakopoulos
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

2.  Predicting Adverse Drug Effects from Literature- and Database-Mined Assertions.

Authors:  Mary K La; Alexander Sedykh; Denis Fourches; Eugene Muratov; Alexander Tropsha
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

3.  Cyclosporine-induced Leukoencephalopathy Precipitated Following Interaction with Ciprofloxacin.

Authors:  Divya Nagabushana; Supraja Chandrasekhar; Stalin Ramprakash; Gurudutt Avathi Venkatesha; Rajesh V Helavar
Journal:  J Pediatr Neurosci       Date:  2021-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.